Sanofi has announced plans to expand its global capability centre in Hyderabad, signalling continued confidence in India’s talent ecosystem. The French drugmaker said the facility will grow to employ more than 4,500 people, up from its current workforce of over 2,600.
The expansion will be backed by a multi-hundred-million-dollar investment, although the company has not revealed the exact figure or a timeline for the hiring push. The move builds on earlier commitments made in 2024, when the biopharmaceutical major outlined plans to invest 400 million euros in its India capability centre by the end of the decade.
New roles are expected to focus on high-skill areas such as research and development, artificial intelligence, data analytics, medical affairs, commercial operations and corporate functions. The hiring strategy reflects how global capability centres have evolved beyond cost-focused support units into strategic hubs that drive innovation and business outcomes.
India has emerged as a preferred destination for multinational firms looking to scale such centres.
The announcement coincides with preparations for BioAsia, scheduled for 17–18 February, where global pharmaceutical leaders including Eli Lilly, Novo Nordisk and Merck KGaA are set to discuss research expansion and the long-term outlook for India’s pharmaceutical industry.
